Charles River Laboratories EBITDA Margin 2010-2024 | CRL

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Charles River Laboratories (CRL) over the last 10 years. The current EBITDA margin for Charles River Laboratories as of September 30, 2024 is .
Charles River Laboratories EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $4.06B $0.87B 21.37%
2024-06-30 $4.08B $0.89B 21.87%
2024-03-31 $4.11B $0.90B 21.81%
2023-12-31 $4.13B $0.93B 22.55%
2023-09-30 $4.22B $0.96B 22.75%
2023-06-30 $4.18B $0.96B 22.86%
2023-03-31 $4.09B $0.98B 23.86%
2022-12-31 $3.98B $0.96B 24.02%
2022-09-30 $3.78B $0.95B 25.23%
2022-06-30 $3.69B $0.95B 25.81%
2022-03-31 $3.63B $0.89B 24.63%
2021-12-31 $3.54B $0.86B 24.15%
2021-09-30 $3.43B $0.81B 23.49%
2021-06-30 $3.27B $0.77B 23.61%
2021-03-31 $3.04B $0.70B 23.04%
2020-12-31 $2.92B $0.67B 22.85%
2020-09-30 $2.82B $0.64B 22.63%
2020-06-30 $2.75B $0.59B 21.54%
2020-03-31 $2.72B $0.59B 21.55%
2019-12-31 $2.62B $0.55B 20.98%
2019-09-30 $2.53B $0.53B 21.04%
2019-06-30 $2.45B $0.52B 21.06%
2019-03-31 $2.38B $0.51B 21.33%
2018-12-31 $2.27B $0.49B 21.76%
2018-09-30 $2.14B $0.45B 20.77%
2018-06-30 $2.02B $0.43B 21.03%
2018-03-31 $1.91B $0.42B 21.94%
2017-12-31 $1.86B $0.42B 22.56%
2017-09-30 $1.85B $0.43B 23.19%
2017-06-30 $1.81B $0.41B 22.84%
2017-03-31 $1.77B $0.39B 22.00%
2016-12-31 $1.68B $0.36B 21.64%
2016-09-30 $1.57B $0.34B 21.35%
2016-06-30 $1.49B $0.32B 21.58%
2016-03-31 $1.40B $0.31B 22.32%
2015-12-31 $1.36B $0.30B 22.16%
2015-09-30 $1.34B $0.29B 21.88%
2015-06-30 $1.32B $0.29B 21.70%
2015-03-31 $1.32B $0.28B 21.38%
2014-12-31 $1.30B $0.28B 21.26%
2014-09-30 $1.26B $0.26B 20.92%
2014-06-30 $1.22B $0.26B 21.13%
2014-03-31 $1.17B $0.25B 21.31%
2013-12-31 $1.17B $0.26B 22.06%
2013-09-30 $1.16B $0.26B 22.75%
2013-06-30 $1.14B $0.26B 22.57%
2013-03-31 $1.14B $0.26B 23.26%
2012-12-31 $1.13B $0.27B 23.45%
2012-09-30 $1.14B $0.27B 23.84%
2012-06-30 $1.14B $0.27B 24.04%
2012-03-31 $1.14B $0.28B 24.50%
2011-12-31 $1.14B $0.28B 24.50%
2011-09-30 $1.13B $0.18B 15.96%
2011-06-30 $1.13B $0.16B 13.75%
2011-03-31 $1.13B $0.14B 11.97%
2010-12-31 $1.13B $0.12B 10.67%
2010-09-30 $1.12B $0.22B 19.89%
2010-06-30 $1.14B $0.25B 22.07%
2010-03-31 $1.16B $0.27B 22.91%
2009-12-31 $1.17B $0.27B 23.40%
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00